BE900381A - NEW INJECTABLE COMPOSITIONS. - Google Patents

NEW INJECTABLE COMPOSITIONS.

Info

Publication number
BE900381A
BE900381A BE0/213510A BE213510A BE900381A BE 900381 A BE900381 A BE 900381A BE 0/213510 A BE0/213510 A BE 0/213510A BE 213510 A BE213510 A BE 213510A BE 900381 A BE900381 A BE 900381A
Authority
BE
Belgium
Prior art keywords
injectable compositions
microns
particles
weight
new injectable
Prior art date
Application number
BE0/213510A
Other languages
French (fr)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of BE900381A publication Critical patent/BE900381A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composition stérile aqueuse injectable pratiquement neutre qui comprend jusqu'à environ 80 % (poids/volume) de métronidazole, le métronidazole étant sous forme de particules ayant une dimension maximum moyenne de 15 à 30 microns et ne contenant pas plus d'environ 10 % en poids de particules ayant une dimension maximum de 10 microns ou moins et pas plus d'environ 10 % en poids de particules ayant une dimension maximum de 80 microns ou plus.A practically neutral aqueous sterile injectable composition which comprises up to approximately 80% (weight / volume) of metronidazole, the metronidazole being in the form of particles having a maximum average size of 15 to 30 microns and containing not more than approximately 10% in weight of particles having a maximum dimension of 10 microns or less and not more than about 10% by weight of particles having a maximum dimension of 80 microns or more.

BE0/213510A 1983-08-19 1984-08-17 NEW INJECTABLE COMPOSITIONS. BE900381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (1)

Publication Number Publication Date
BE900381A true BE900381A (en) 1985-02-18

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213510A BE900381A (en) 1983-08-19 1984-08-17 NEW INJECTABLE COMPOSITIONS.

Country Status (17)

Country Link
JP (1) JPS6067468A (en)
AU (1) AU577055B2 (en)
BE (1) BE900381A (en)
CA (1) CA1214727A (en)
CH (1) CH662812A5 (en)
DE (1) DE3430354A1 (en)
DK (1) DK165817C (en)
FR (1) FR2560043B1 (en)
GB (2) GB8322364D0 (en)
HU (1) HU192990B (en)
IL (1) IL72714A (en)
IT (1) IT1213208B (en)
LU (1) LU85511A1 (en)
NL (1) NL8402510A (en)
NZ (1) NZ209270A (en)
SE (1) SE460095B (en)
ZA (1) ZA846431B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194638C (en) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol.
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (en) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimycotic tablets contg. micronised azole derivs. - together with acid and/or buffer

Also Published As

Publication number Publication date
IT1213208B (en) 1989-12-14
ZA846431B (en) 1985-03-27
JPS6067468A (en) 1985-04-17
DE3430354A1 (en) 1985-03-07
DK397084A (en) 1985-02-20
FR2560043B1 (en) 1988-08-05
GB8420959D0 (en) 1984-09-19
FR2560043A1 (en) 1985-08-30
GB2145088B (en) 1986-10-08
CA1214727A (en) 1986-12-02
NL8402510A (en) 1985-03-18
NZ209270A (en) 1988-02-29
IL72714A (en) 1988-09-30
LU85511A1 (en) 1985-04-24
DK397084D0 (en) 1984-08-17
DK165817C (en) 1993-06-21
HU192990B (en) 1987-08-28
CH662812A5 (en) 1987-10-30
AU3202284A (en) 1985-02-21
IT8422323A0 (en) 1984-08-13
HUT35650A (en) 1985-07-29
SE8404130D0 (en) 1984-08-17
DK165817B (en) 1993-01-25
GB2145088A (en) 1985-03-20
SE460095B (en) 1989-09-11
SE8404130L (en) 1985-02-20
AU577055B2 (en) 1988-09-15
GB8322364D0 (en) 1983-09-21

Similar Documents

Publication Publication Date Title
ATE24325T1 (en) PUMPABLE CONCENTRATED DISPERSIONS OF WATER-SOLUBLE POLYMERS.
FR2432536A1 (en) SILICONE EMULSION FOR THE TREATMENT OF SILICATE-BASED PARTICULATE MATERIALS
DE69310518T2 (en) PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION CONTAINING A CROSSLINKED CATIONIC POLYMER AND AN ALKOXYLATED ETHER
ATE19264T1 (en) AQUEOUS CARBON DISPERSIONS.
MY102296A (en) Antimicrobial suspensions and antimicrobial hair treatment compositions
FI873092A (en) Polymer particle and the water dispersion, method of preparation and use
ES8800605A1 (en) Composition for ophthalmological use.
DE69329792D1 (en) COMPOSITION OF ANTINEOPLASTIC ACTIVE SUBSTANCES INCLUDED IN MICELS
ES8600335A1 (en) Compositions containing a copolymerisate and a tensioactive agent, their use and preparation.
AU2968089A (en) Emulsion compositions including amphipathic emulsifying agents
ES8303473A1 (en) Polyethers modified with alpha olefin oxides.
KR950703662A (en) STEEL CONTAINING SUPER-FINELY DOSPERSED OXIDE SYSTEM INCLUSIONS
ATE42758T1 (en) COMPOSITIONS OF BIOPOLYMERS AND PROCESSES FOR THEIR PRODUCTION.
FR2742048B1 (en) USE OF 2-ETHYLHEXYL ALPHA-CYANO-BETA, BETA-DIPHENYLACRYLATE TO IMPROVE THE STABILITY OF COSMETIC COMPOSITIONS CONTAINING P-METHYL-BENZYLIDENE CAMPHOR IN ASSOCIATION WITH A DIBENZOYLMETH DERIVATIVE
BE900381A (en) NEW INJECTABLE COMPOSITIONS.
DE69802504T2 (en) AL-MG-SI ALLOY WITH GOOD EXPRESS PROPERTIES
ATE38165T1 (en) COMPOSITIONS INCLUDING A SURFACE ACTIVE AGENT.
KR870009724A (en) Antacids with Preservative Properties and Manufacturing Method Thereof
FR2469711A1 (en) IMMUNOPOTENTIALIZER CONTAINING RICIN AND THERAPEUTIC COMPOSITION CONTAINING THE SAME
BR9007022A (en) ANTI-SMOKING AGENTS AND THEIR APPLICATION
ES8202853A1 (en) Dyestuffs, process for their preparation as well as their use in dyeing materials containing hydroxyl groups or nitrogen.
HUP9802931A2 (en) Improvements relating to hard surface cleaning composition
EP0213330A3 (en) Process for the preparation of a cycloaliphatic diepoxide
FR2469712A1 (en) ABRINE-CONTAINING IMMUNOPOTENTIALIZER AND THERAPEUTIC COMPOSITION CONTAINING THE SAME
DE3780934D1 (en) AQUEOUS COMPOSITION FOR UNIVERSAL "SPACER" AND THEIR USE IN THE FIELD OF PRODUCING DRILL HOLES, ESPECIALLY OIL AND GAS DRILL HOLES.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MAY & BAKER LTD

Effective date: 19940831